128 related articles for article (PubMed ID: 31658131)
1. A dual cancer-specific recombinant adenovirus suppresses the growth of liver cancer cells in vivo and in vitro.
Tian Y; Yao W; He D; Xu Y; Li Y; Zhu Y; Fang J; Bai B; Li X; Sun L; Jin N
Anticancer Drugs; 2020 Feb; 31(2):110-122. PubMed ID: 31658131
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor effect of a dual cancer-specific recombinant adenovirus on ovarian cancer cells.
Cui Y; Li Y; Li S; Li W; Zhu Y; Wang J; Liu X; Yue Y; Jin N; Li X
Exp Cell Res; 2020 Nov; 396(1):112185. PubMed ID: 32828827
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of a dual cancer-specific oncolytic adenovirus on prostate cancer PC-3 cells.
Cui CX; Li YQ; Sun YJ; Zhu YL; Fang JB; Bai B; Li WJ; Li SZ; Ma YZ; Li X; Wang WH; Jin NY
Urol Oncol; 2019 Jun; 37(6):352.e1-352.e18. PubMed ID: 30665692
[TBL] [Abstract][Full Text] [Related]
4. Suppression effect of a dual cancer-specific oncolytic adenovirus on luciferase-labeled human melanoma cells in vitro and in vivo.
Li M; Zhu Y; Bai B; Fang J; Yao W; Li Y; Li S; Li X; Jin N; Jiang R
Cancer Biomark; 2021; 32(3):251-262. PubMed ID: 34459386
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide.
Li T; Fang J; Chu J; Liu X; Li Y; Zhu Y; Li S; Xiu Z; Li Y; Jin N; Zhu G; Sun L; Li X
J Cancer Res Clin Oncol; 2022 May; 148(5):1073-1085. PubMed ID: 35038020
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor Synergistic Effect of a Dual Cancer-Specific Recombinant Adenovirus and Paclitaxel on Breast Cancer.
Wang J; Li Y; Li S; Yao W; Liu X; Zhu Y; Li W; Sun L; Jin N; Li X
Front Oncol; 2020; 10():244. PubMed ID: 32269962
[TBL] [Abstract][Full Text] [Related]
7. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
Liu L; Wu W; Zhu G; Liu L; Guan G; Li X; Jin N; Chi B
Int J Mol Med; 2012 Oct; 30(4):747-54. PubMed ID: 22842823
[TBL] [Abstract][Full Text] [Related]
9. Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine.
Liu X; Yang Z; Li Y; Zhu Y; Li W; Li S; Wang J; Cui Y; Shang C; Liu Z; Song G; Li C; Li X; Shao G; Jin N
Front Oncol; 2020; 10():229. PubMed ID: 32158698
[TBL] [Abstract][Full Text] [Related]
10. HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.
Xu HN; Huang WD; Cai Y; Ding M; Gu JF; Wei N; Sun LY; Cao X; Li HG; Zhang KJ; Liu XR; Liu XY
Mol Cancer; 2011 Nov; 10():133. PubMed ID: 22040050
[TBL] [Abstract][Full Text] [Related]
11. Autophagy promotes oncolysis of an adenovirus expressing apoptin in human bladder cancer models.
Shang C; Zhu YL; Li YQ; Song GJ; Ge CC; Lu J; Xiu ZR; Li WJ; Li SZ; Cong JN; Liu ZR; Li X; Sun LL; Jin NY
Invest New Drugs; 2021 Aug; 39(4):949-960. PubMed ID: 33534026
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the ability of recombinant oncolytic adenovirus, doxorubicin and tamoxifen to inhibit the proliferation of breast cancer cells.
Li S; Li Z; Li Y; Zhu Y; Han J; Li W; Jin N; Fang J; Li X; Zhu G
J Cell Mol Med; 2022 Oct; 26(20):5222-5234. PubMed ID: 36148613
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo.
Wang J; Zuo S; Zhang Y; Li S; Shi Y; Du T; Han J; Jin N; Li Y; Li X
Cancer Manag Res; 2022; 14():2749-2761. PubMed ID: 36133740
[TBL] [Abstract][Full Text] [Related]
14. Ad-apoptin inhibits glycolysis, migration and invasion in lung cancer cells targeting AMPK/mTOR signaling pathway.
Song G; Fang J; Shang C; Li Y; Zhu Y; Xiu Z; Sun L; Jin N; Li X
Exp Cell Res; 2021 Dec; 409(2):112926. PubMed ID: 34793774
[TBL] [Abstract][Full Text] [Related]
15. Potent growth-inhibitory effect of a dual cancer-specific oncolytic adenovirus expressing apoptin on prostate carcinoma.
Zhang M; Wang J; Li C; Hu N; Wang K; Ji H; He D; Quan C; Li X; Jin N; Li Y
Int J Oncol; 2013 Mar; 42(3):1052-60. PubMed ID: 23338489
[TBL] [Abstract][Full Text] [Related]
16. Intratumor injection of oncolytic adenovirus expressing HSP70 prolonged survival in melanoma B16 bearing mice by enhanced immune response.
Ren Z; Ye X; Fang C; Lu Q; Zhao Y; Liu F; Liang M; Hu F; Chen HZ
Cancer Biol Ther; 2008 Feb; 7(2):191-95. PubMed ID: 18073525
[TBL] [Abstract][Full Text] [Related]
17. Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo.
Li X; Liu Y; Wen Z; Li C; Lu H; Tian M; Jin K; Sun L; Gao P; Yang E; Xu X; Kan S; Wang Z; Wang Y; Jin N
Mol Cancer; 2010 Jan; 9():10. PubMed ID: 20085660
[TBL] [Abstract][Full Text] [Related]
18. Cancer targeting gene-viro-therapy specific for liver cancer by α-fetoprotein-controlled oncolytic adenovirus expression of SOCS3 and IL-24.
Cao X; Wei R; Liu X; Zeng Y; Huang H; Ding M; Zhang K; Liu XY
Acta Biochim Biophys Sin (Shanghai); 2011 Oct; 43(10):813-21. PubMed ID: 21835849
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
[TBL] [Abstract][Full Text] [Related]
20. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
